Effect of Edaravone Combined with Anticoagulant Therapy on the Serum hs-CRP, IL-6, and TNF-α Levels and Activity of Daily Living in Patients with Acute Cerebral Infarction

Table 2

Comparison of clinical data (n = 42).

Items	Routine group	Combined group	χ^2/t	value
Gender			0.192	0.661
Male/female	24/18	22/20
Body weight (mean ± SD, kg)	73.16 ± 5.43	73.41 ± 5.90	0.202	0.840
Average age (mean ± SD, years old)	60.38 ± 3.77	60.74 ± 3.39	0.460	0.647
Onset time (mean ± SD, h)	23.45 ± 4.61	23.83 ± 3.94	0.406	0.686
Diseased sites
Brainstem	15 (35.71)	13 (30.95)	0.214	0.643
Internal capsule	21 (50.00)	19 (45.24)	0.191	0.662
Lateral frontotemporal lobe	6 (14.29)	10 (23.81)	1.235	0.266
Combined diseases
Hyperlipidemia	8 (19.05)	9 (21.43)	0.074	0.786
Hypertension	14 (33.33)	12 (28.57)	0.223	0.637
Coronary heart disease	15 (35.71)	13 (30.95)	0.214	0.643
Diabetes	5 (11.90)	8 (19.05)	0.819	0.365
Smoking history	13 (30.95)	16 (38.10)	0.474	0.491
Drinking history	17 (40.48)	19 (45.24)	0.194	0.659
Disease types
Monofocal type	18 (42.86)	16 (38.10)	0.198	0.657
Multifocal type	10 (23.81)	13 (30.95)	0.539	0.463
Lacunar type	14 (33.33)	13 (30.95)	0.055	0.815
Marital status
Married	35 (83.33)	37 (88.10)	0.389	0.533
Unmarried	4 (9.52)	3 (7.14)	0.156	0.693
Divorced	3 (7.14)	2 (4.76)	0.213	0.645
Residence			0.192	0.661
Urban area	18 (42.86)	20 (47.62)
Rural area	24 (57.14)	22 (52.38)